Skip to content

Drug interactions

Brentuximab vedotin + Oxcarbazepine

Severity: Minor

Brentuximab vedotin and Oxcarbazepine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brentuximab vedotin releases the toxin MMAE, which is a CYP3A4 substrate. Oxcarbazepine could lower MMAE exposure, but the effect is likely modest and not clearly clinically important.

What this interaction means in plain words

Brentuximab vedotin and Oxcarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Brentuximab vedotin belongs to Oncology; Oxcarbazepine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by oxcarbazepine may modestly increase MMAE clearance.

What to do

No dose change is needed; monitor treatment response as usual.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Oxcarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab vedotin with Oxcarbazepine?

MediHelp rates the interaction as minor. Brentuximab vedotin and Oxcarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Brentuximab vedotin releases the toxin MMAE, which is a CYP3A4 substrate. Oxcarbazepine could lower MMAE exposure, but the effect is likely modest and not clearly clinically important.

How serious is the interaction between Brentuximab vedotin and Oxcarbazepine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor treatment response as usual.

What other medicines interact with Oxcarbazepine?

MediHelp also lists interactions of Oxcarbazepine with, for example, Cabotegravir, Rilpivirine, Artemether / lumefantrine. The full list is on the Oxcarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in